Creative Medical Technology Holdings is a biotechnology business based in the US. Creative Medical Technology Holdings shares (CELZ) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.48 – an increase of 7.69% over the previous week. Creative Medical Technology Holdings employs 4 staff and has a trailing 12-month revenue of around $17,000.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $4.48 |
|---|---|
| 52-week range | $2.65 - $7.44 |
| 50-day moving average | $3.35 |
| 200-day moving average | $4.15 |
| Wall St. target price | $30.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-4.07 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $5.3 from 2024-10-15
| 1 week (2024-10-11) | 24.62% |
|---|---|
| 1 month (2024-09-18) | 63.08% |
| 3 months (2024-07-18) | 39.47% |
| 6 months (2024-04-18) | 10.19% |
| 1 year (2023-10-18) | 11.58% |
|---|---|
| 2 years (2022-10-18) | 1,275.55% |
| 3 years (2021-10-18) | 8 |
| 5 years (2019-10-18) | 52.5 |
| Revenue TTM | $17,000 |
|---|---|
| Gross profit TTM | $39,805 |
| Return on assets TTM | -34.27% |
| Return on equity TTM | -53.71% |
| Profit margin | 0% |
| Book value | $5.69 |
| Market Capitalization | $7.1 million |
TTM: trailing 12 months
Creative Medical Technology Holdings's shares were split on a 1:10 basis on 11 June 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Creative Medical Technology Holdings shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Creative Medical Technology Holdings shares which in turn could have impacted Creative Medical Technology Holdings's share price.
Over the last 12 months, Creative Medical Technology Holdings's shares have ranged in value from as little as $2.65 up to $7.4444. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Creative Medical Technology Holdings's is 5.023. This would suggest that Creative Medical Technology Holdings's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put Creative Medical Technology Holdings's beta into context you can compare it against those of similar companies.
Creative Medical Technology Holdings, Inc. , a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease. It also develops ImmCelz, an immunotherapy platform for multiple diseases; OvaStem for treatment of female infertility; CELZ-201 to treat Type 1 diabetes; AlloStemSpine for the treatment of chronic lower back pain; and Alova to treat infertility as a result of premature ovarian failure. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
What you need to know about investing in the leading indicator for the overall US stock market.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Read our beginner’s guide to trading options in the US.